Matriks Biotek

Matriks Biotek® Co., is a biotechnology company committed to the R&D and innovation of immune based, molecules and tools.
In the market with biological drug testing SHIKARI® ELISA kits suitable to monitor the use of biologics, mainly humanized recombinant monoclonal antibodies, in certain diseases as pharmaceutical drugs elicits the question of effectiveness in each individually treated person. Monitoring drug levels and antibodies plays an emerging role in the management of lack- or loss of response to recombinant and/or humanized antibodies (i.e., to confirm treatment continuation, adjustment to dose, provide a rationale for switching to another agent or to a different class of biological agent).

Major areas of interest are as follows;

Biological drug testing
Biotherapeutics and novel markers for diseases
Inflammation and Immunology
Obesity, type II diabetes and cardiovascular diease
Infectious diseases
Oncology
On follow the list of Kits available, pls contact info@labospace.com for any information

Reference Code Description
INF-FD-REMI0201 ELISA of free Infliximab (Remicade®) in serum and plasma
INF-QLS-REMI0501 ELISA for the qualitative determination of specific antibodies to infliximab in human serum and plasma with confirmation
INF-QNS-REMI0601 ELISA of specific antibodies to infliximab in human serum and plasma with confirmation
INF-QNFT-REMI0801 ELISA for the semi-quantitative determination (screening) of total and free antibodies to infliximab (Remicade®) in serum and plasma.
ADA-FD-HUM0101 ELISA of free adalimumab (Humira®) in serum and plasma
ADA-QLS-HUM0101 ELISA for the qualitative determination of antibodies to adalimumab (Humira®) in serum and plasma with confirmation
ADA-QNS-HUM0201 ELISA of antibodies to adalimumab (Humira®) in serum and plasma with confirmation
ADA-QNFT-HUM0401 ELISA for the semi-quantitative determination (screening) of total and free antibodies to adalimumab (Humira®) in serum and plasma
ETA-FD-ENB0201 ELISA of free Etanercept (Enbrel) in serum and plasma
ETA-QLS-ENB0201 ELISA for the qualitative determination of antibodies to etanercept in serum and plasma
BEV-FD-AVA0201 ELISA of Bevacizumab (Avastin®) in serum and plasma
BEV-QLS-AVA0101 ELISA for the qualitative determination of antibodies to Bevacizumab (Avastin®) in serum and plasma
BEV-QNS-AVA0201 ELISA of antibodies to Bevacizumab (Avastin®) in serum and plasma
RIT-FD-RM0201 ELISA of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
RIT-QLS-RM0101 ELISA for the qualitative determination of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
RIT-QNS-RM0201 ELISA of antibodies to Rituximab® (Rituxan®, Mabthera®) in serum and plasma
TRA-FD-HH0201 ELISA of Trastuzumab (Herceptin®, Herclon®)
TRA-QLS-HH0101 ELISA for the qualitative determination of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma
TRA-QNS-HH0201 ELISA of antibodies to Trastuzumab (Herceptin®, Herclon®) in serum and plasma
GOL-FD-SIM0101 ELISA of free Golimumab (Simponi®) in serum and plasma.
GOL-QLS-SIM0101 ELISA for the qualitative determination of antibodies to Golimumab in serum and plasma.
CET-FD-ERB0101 ELISA of free Cetuximab (Erbitux®) in serum and plasma.
CET-QLS-ERB0101 ELISA for the qualitative determination of antibodies to cetuximab in serum and plasma.
CET-QNS-ERB0201 ELISA of antibodies to cetuximab in serum and plasma.
INF-FD-REMS0101 ELISA of free Infliximab (Remsima®) in serum and plasma.
INF-QLS-REMS0101 ELISA for the qualitative determination of antibodies to Infliximab Remsima in serum and plasma.
INF-QNS-REMS0201 ELISA of antibodies to Infliximab Remsima in serum and plasma.
INF-QNT-REMS0301 ELISA for the semi-quantitative determination (screening) of total antibodies to Infliximab biosimilar (Remsima®) in serum and plasma.
DEN-FD-PRO0101 ELISA of Denosumab (Prolia®)in serum and plasma.
DEN-QLS-PRO0101 ELISA for the qualitative determination of antibodies to Denosumab in serum and plasma.
OMA-FD-XOL0101 ELISA of Omalizumab (Xolair®) Remsima in serum and plasma.
OMA-QLS-XOL0101 ELISA for the qualitative determination of antibodies to Omalizumab in serum and plasma.
NIV-FD-OPD0101 ELISA of Nivolumab (Opdivo®) in serum and plasma.
NIV-QLS-OPD0101 ELISA for the qualitative determination of antibodies to Nivolumab in serum and plasma.
PEM-FD-KEY0101 ELISA of Pembrolizumab (Keytruda®) in serum and plasma.
PEM-QLS-KEY0101 ELISA for the qualitative determination of antibodies to Pembrolizumab in serum and plasma.
FIL-QNS-FIL0101 ELISA of specific anibodies to Filgrastim in serum and plasma.
IPI-FD-YER0101 ELISA of specific Ipilimumab (Yervoy®) in human serum and plasma.
IPI-QLS-YER0101 ELISA for the qualitative determination of specific antibodies to Ipilimumab in serum and plasma.
AVE-FD-BAV0101 ELISA of specific Avelumab (Bavencio®) in human serum and plasma.
AVE-QLS-BAV0101 ELISA for the qualitative determination of specific antibodies to Avelumab in serum and plasma.
RAN-FD-LUC0101 ELISA of free Ranibizumab in aqueous humour.
RAM-FD-CYR0101 ELISA of free Ramucirumab in serum and plasma.
RAM-QLS-CYR0101 ELISA for the qualitative determination of antibodies to Ramucirumab in serum and plasma.
CER-FD-CIM0201 ELISA of Certolizumab in human serum and plasma
VED-FD-ENT0101 ELISA of Vedolizumab in human serum and plasma
VED-QLS-ENT0101 ELISA for the qualitative determination of antibodies to Vedolizumab in human serum and plasma
UST-FD-STE0101 ELISA of Ustekinumab in human serum and plasma
UST-QLS-STE0101 ELISA for the qualitative determination of antibodies to Ustekinumab in human serum and plasma